Skip to main content
J Frontier Co.,Ltd. logo

J Frontier Co.,Ltd. — Investor Relations & Filings

Ticker · 2934 ISIN · JP3386650000 LEI · 353800HXWRYUK3D9E382 T Human health and social work activities
Filings indexed 56 across all filing types
Latest filing 2026-04-22 Regulatory Filings
Country JP Japan
Listing T 2934

About J Frontier Co.,Ltd.

https://jfrontier.jp/

J Frontier Co., Ltd. is a healthcare technology company primarily engaged in the e-commerce of pharmaceuticals and health-related products. The company operates through several key business areas: healthcare sales, which includes the planning, manufacturing, and sale of its own health foods and beauty products; medical sales, focusing on an online medication guidance and prescription drug mail-order platform; and healthcare marketing, which provides digital marketing and promotional support to other companies. By leveraging digital technology, J Frontier aims to drive the digital transformation of the medical and pharmaceutical sectors, making healthcare services more accessible and contributing to the overall health and well-being of society.

Recent filings

Filing Released Lang Actions
自治体向け防災医療ソリューション事業の開始に関するお知らせ
Regulatory Filings
2026-04-22 Japanese
2026年5月期 第3四半期決算説明資料
Regulatory Filings
2026-04-14 Japanese
2026年5月期 第3四半期決算短信[日本基準](連結)
Regulatory Filings
2026-04-14 Japanese
確認書
Regulatory Filings Classification · 100% confidence The document is a 'Confirmation Letter' (確認書) filed under the Financial Instruments and Exchange Act. It serves as an officer certification regarding the accuracy of a previously filed semi-annual report. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations, even if they reference a report (like a semi-annual report), should be classified as Regulatory Filings (RNS) rather than the report itself. H1 18
2026-01-14 Japanese
半期報告書-第18期(2025/06/01-2026/05/31)
Interim / Quarterly Report Classification · 100% confidence The document is a '半期報告書' (Semi-Annual Report) filed under the Financial Instruments and Exchange Act of Japan. It contains comprehensive financial statements, management analysis (MDA), and corporate information for the interim period (2025-06-01 to 2025-11-30). This fits the definition of an Interim/Quarterly Report (IR) as it provides substantive financial data and analysis for a period shorter than a full fiscal year. H1 2025
2026-01-14 Japanese
有価証券届出書(通常方式)
Capital/Financing Update Classification · 100% confidence The document is a '有価証券届出書' (Securities Registration Statement) filed with the Kanto Local Finance Bureau by J Frontier Co., Ltd. It details a third-party allotment of shares (capital increase) to raise funds for marketing and business expansion. This type of filing is a formal regulatory document related to capital structure changes and financing activities, which falls under the 'CAP' (Capital/Financing Update) category.
2025-09-02 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.